Ronald Chapman, LLM, Shareholder and Chairperson of White Collar Defense & Government Investigations at Chapman Law Group, delves into the intricate intersections of law and daily life, highlighting the sub-specialized nature of healthcare law and his primary areas of focus within this field.
Chapman offers insights into his strategic choices between judge and jury trials, providing a nuanced perspective on opioid prescriptions, and delineates the fine line between lawful and unlawful practices. Ronald also unpacks the complex legal nuances involved in cases of unlawful opioid prescriptions, offering listeners a deep dive into the legal challenges and considerations in these critical issues.
N/A
Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
